Results 141 to 150 of about 48,920 (248)

Relationship Between Serum HMGB1 and RAGE Levels and Restenosis in Type 2 Diabetes Mellitus Patients Complicated With Lower Extremity Vascular Disease: A Retrospective Study

Ting Jia,* Xuyan Zhang,* Li Li, Xiaowan Jiang, Mengjie Wang Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China*These ...
Wang M, Jia T, Zhang X, Jiang X, Li L
core  

Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery: an Intravascular Ultrasound Study

, 2008
The objective of this prospective randomized study was to verify whether the superiority of the sirolimus-eluting stent (SES) in inhibiting neointimal hyperplasia could be demonstrated in complex coronary lesions. The SES was compared with the paclitaxel-
BRANCHITTA, GIULIA
core  

Peculiarities of in-Stent Thrombosis and Restenosis in Coronary Arteries Post-COVID-19: A Systematic Review of Clinical Cases and Case Series

Lyudmila Pivina,1 Gulnara Batenova,1 Nazarbek Omarov,1 Diana Ygiyeva,1 Assylzhan Messova,1 Galiya Alibayeva,2 Ulzhan Jamedinova,1 Ruslan Kurumbayev,1 Maksim Pivin3 1Department of Emergency Medicine, Semey Medical University, Semey, Abay Region ...
Batenova G, Omarov N, Kurumbayev R, Pivin M, Ygiyeva D, Alibayeva G, Jamedinova U, Pivina L, Messova A   +8 more
core  

Restenosis [PDF]

Circulation, 2003
openaire   +2 more sources

Pathogenetic factor and prevention of vascular restenosis [PDF]

Both percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA) are useful for the treatment of patients with vascular stenosis. However, restenosis occurs among 30% to 40% of those treated within six months.
Kosugi, Tadayoshi, Nakamura, Mariko, 吉長, 正富, Murayama, Sadayuki, 砂川, 昌範, Sunagawa, Masanori, 村山, 貞之, 小杉忠誠, Shimada, Seiji, Kinjoh, Kiyohiko, 島田, 誠二, 金城, 紀代彦, Yoshinaga, Masatomi, 中村, 真理子   +13 more
core  

Antioxidant system gene polymorphism and restenosis risk after coronary stenting

Кардиоваскулярная терапия и профилактика, 2008
Aim. To study the links between four polymorphisms of three antioxidant enzymes (catalase, paraoxonase, endothelial NO synthase) and restenosis risk after coronary artery stenting (CAS).Material and methods. The study included male patients with coronary
Yu. A. Shuvalova, A. N. Meshkov, A. I. Kaminny, A. N. Samko, R. O. Shirokov, D. V. Stambolsky, V. V. Kukharchuk   +6 more
doaj  

Neointimal hyperplasia and vascular restenosis: from molecular mechanisms to therapeutic interventions. [PDF]

Mol Biomed
Yi L, Chen T, Zhou Y, Zhu P, Zhu Q, Shao Y, Yao W.   +6 more
europepmc   +1 more source

Metabolic Signatures in Pericardial Fluid and Serum Are Associated with Long-Term Restenosis After Isolated Coronary Artery Bypass Grafting. [PDF]

J Clin Med
Zhou X, Zheng L, Du Z, Luo J, Hua K, Yang X.   +5 more
europepmc   +1 more source

Usefulness of metabolic score for insulin resistance to predict restenosis after coronary stent implantation. [PDF]

Ann Med
Tang J, Xu P, Guo J, Hao P.
europepmc   +1 more source

Optimizing Reconstruction Parameters for Detecting Peripheral In-Stent Restenosis with Photon-Counting Detector CT: A Phantom Study. [PDF]

Diagnostics (Basel)
Tan Y, Hop JF, Dobrolinska M, Zheng X, Hoeijmakers EJI, de Vries JPM, Greuter MJW, Bokkers RPH.   +7 more
europepmc   +1 more source